Endovia Health Sciences annual ebitda
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Endovia Health Sciences EBITDA Growth & History (EDVA)
Endovia Health Sciences's calculated EBITDA was −$14.2M for fiscal 2025.
View full Endovia Health Sciences company overviewEndovia Health Sciences annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$14.2M | −$4.7M | — |
| 2024 | 2024-12-31 | −$9.5M | $5.2M | — |
| 2023 | 2023-12-31 | −$14.7M | $5.7M | — |
| 2022 | 2022-12-31 | −$20.5M | $8.5M | — |
| 2021 | 2021-12-31 | −$29.0M | −$11.4M | — |
| 2020 | 2020-12-31 | −$17.5M | −$13.1M | — |
| 2019 | 2019-12-31 | −$4.5M | −$4.6M | — |
| 2018 | 2018-12-31 | $129,500 | $214,789 | — |
| 2017 | 2017-12-31 | −$85,289 | −$91,048 | — |
| 2016 | 2016-12-31 | $5,759 | −$42,903 | −88.17% |
| 2015 | 2015-12-31 | $48,662 | $48,447 | +22533.49% |
| 2014 | 2014-12-31 | $215 | −$2,315 | −91.50% |
| 2013 | 2013-12-31 | $2,530 | — | — |
Endovia Health Sciences quarterly ebitda
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$2.0M | −$499,412 | — |
| Q1 2026 | 2026-03-31 | −$976,649 | $679,333 | — |
| Q4 2025 | 2025-12-31 | −$1.6M | −$1.3M | — |
| Q3 2025 | 2025-09-30 | −$9.4M | −$6.9M | — |
| Q2 2025 | 2025-06-30 | −$1.5M | $2.1M | — |
| Q1 2025 | 2025-03-31 | −$1.7M | $1.5M | — |
| Q4 2024 | 2024-12-31 | −$293,350 | $2.9M | — |
| Q3 2024 | 2024-09-30 | −$2.5M | $1.7M | — |
| Q2 2024 | 2024-06-30 | −$3.6M | $528,389 | — |
| Q1 2024 | 2024-03-31 | −$3.1M | $209,237 | — |
| Q4 2023 | 2023-12-31 | −$3.1M | $996,702 | — |
| Q3 2023 | 2023-09-30 | −$4.2M | $873,474 | — |
| Q2 2023 | 2023-06-30 | −$4.1M | $1.7M | — |
| Q1 2023 | 2023-03-31 | −$3.3M | $2.2M | — |
| Q4 2022 | 2022-12-31 | −$4.1M | $1.6M | — |
| Q3 2022 | 2022-09-30 | −$5.1M | $7.0M | — |
| Q2 2022 | 2022-06-30 | −$5.8M | $925,893 | — |
| Q1 2022 | 2022-03-31 | −$5.5M | −$1.0M | — |
| Q4 2021 | 2021-12-31 | −$5.8M | $7.7M | — |
| Q3 2021 | 2021-09-30 | −$12.0M | −$9.9M | — |
| Q2 2021 | 2021-06-30 | −$6.7M | −$6.3M | — |
| Q1 2021 | 2021-03-31 | −$4.5M | −$2.9M | — |
| Q4 2020 | 2020-12-31 | −$13.4M | −$10.6M | — |
| Q3 2020 | 2020-09-30 | −$2.2M | −$1.3M | — |
| Q2 2020 | 2020-06-30 | −$404,728 | −$98,382 | — |
| Q1 2020 | 2020-03-31 | −$1.5M | −$1.1M | — |
| Q4 2019 | 2019-12-31 | −$2.9M | −$2.9M | — |
| Q3 2019 | 2019-09-30 | −$859,227 | −$871,573 | — |
| Q2 2019 | 2019-06-30 | −$306,346 | −$392,569 | — |
| Q1 2019 | 2019-03-31 | −$445,575 | −$474,161 | — |
| Q4 2018 | 2018-12-31 | $2,345 | $89,596 | — |
| Q3 2018 | 2018-09-30 | $12,346 | −$35,143 | −74.00% |
| Q2 2018 | 2018-06-30 | $86,223 | $83,979 | +3742.38% |
| Q1 2018 | 2018-03-31 | $28,586 | $76,357 | — |
| Q4 2017 | 2017-12-31 | −$87,251 | −$61,058 | — |
| Q3 2017 | 2017-09-30 | $47,489 | $42,596 | +870.55% |
| Q2 2017 | 2017-06-30 | $2,244 | −$2,649 | −54.14% |
| Q1 2017 | 2017-03-31 | −$47,771 | −$69,937 | — |
| Q4 2016 | 2016-12-31 | −$26,193 | −$89,494 | — |
| Q3 2016 | 2016-09-30 | $4,893 | $18,162 | — |
| Q2 2016 | 2016-06-30 | $4,893 | $13,813 | — |
| Q1 2016 | 2016-03-31 | $22,166 | $14,616 | +193.59% |
| Q4 2015 | 2015-12-31 | $63,301 | $74,957 | — |
| Q3 2015 | 2015-09-30 | −$13,269 | −$9,797 | — |
| Q2 2015 | 2015-06-30 | −$8,920 | −$7,701 | — |
| Q1 2015 | 2015-03-31 | $7,550 | −$9,012 | −54.41% |
| Q4 2014 | 2014-12-31 | −$11,656 | — | — |
| Q3 2014 | 2014-09-30 | −$3,472 | — | — |
| Q2 2014 | 2014-06-30 | −$1,219 | — | — |
| Q1 2014 | 2014-03-31 | $16,562 | — | — |
Endovia Health Sciences ebitda trends
Over the last five fiscal years, Endovia Health Sciences's ebitda increased from −$17.5M to −$14.2M, a change of $3.4M. The latest reported quarter, Q2 2026, shows −$2.0M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Endovia Health Sciences source filings ↗